Mutational Analyses of Connexin 26, Connexin 30 and Connexin 46 as Candidate Tumor Suppressor Genes in Parathyroid Carcinoma

Acquired loss of heterozygosity or deletion on 13q is frequently detected in parathyroid carcinoma, suggesting the presence of a parathyroid tumor suppressor gene in this location. Connexins make up the functional unit of gap junctional intercellular communication (GJIC), forming channels allowing passage of small molecules and ions between adjacent cells. Defects in GJIC have been observed in tumor cells and decreased cyclin D1 expression has resulted from forced connexin expression in cancer cells. Given the evidence suggesting 13q-based connexins as important candidate parathyroid tumor suppressors, we tested this hypothesis by examining the coding regions of connexin 26, connexin 30 and connexin 46 for somatic mutations in 13 parathyroid carcinomas. No mutations, insertions, or microdeletions were detected. Based on the absence of identifiable inactivating mutations, it is highly unlikely that connexin 26, connexin 30 or connexin 46 commonly function as classical tumor suppressor genes in the pathogenesis of parathyroid carcinoma.

[1]  V. Krutovskikh,et al.  Altered homologous and heterologous gap‐junctional intercellular communication in primary human liver tumors associated with aberrant protein localization but not gene mutation of connexin 32 , 2007, International journal of cancer.

[2]  E. Shane,et al.  CHAPTER 33 – Parathyroid Carcinoma , 2001 .

[3]  S. Marx Hyperparathyroid and hypoparathyroid disorders. , 2000, The New England journal of medicine.

[4]  L. Dwyer-Nield,et al.  Growth inhibition in G1 and altered expression of cyclin D1 and p27kip‐1 after forced connexin expression in lung and liver carcinoma cells , 2000, Journal of cellular biochemistry.

[5]  C. Larsson,et al.  Patterns of chromosomal imbalances in parathyroid carcinomas. , 2000, The American journal of pathology.

[6]  K. Ishak,et al.  Human hemangiosarcomas have a common polymorphism but no mutations in the connexin37 gene , 2000, International journal of cancer.

[7]  W. Kimberling,et al.  Prevalent connexin 26 gene (GJB2) mutations in Japanese , 2000, Journal of medical genetics.

[8]  S. Bhattacharya,et al.  Connexin46 mutations in autosomal dominant congenital cataract. , 1999, American journal of human genetics.

[9]  E. Schröck,et al.  Comparative genomic hybridization analysis of human parathyroid tumors. , 1998, Cancer genetics and cytogenetics.

[10]  N. Palanisamy,et al.  Novel chromosomal abnormalities identified by comparative genomic hybridization in parathyroid adenomas. , 1998, The Journal of clinical endocrinology and metabolism.

[11]  J. W. Askew,et al.  Novel mutations in the connexin 26 gene (GJB2) that cause autosomal recessive (DFNB1) hearing loss. , 1998, American journal of human genetics.

[12]  J. Trosko,et al.  Cell-cell communication in carcinogenesis. , 1998, Frontiers in bioscience : a journal and virtual library.

[13]  D. Haber,et al.  Tumour-suppressor genes: evolving definitions in the genomic age , 1997, Nature Genetics.

[14]  H. Yamasaki,et al.  Connexin 37 mutations in rat hepatic angiosarcomas induced by vinyl chloride. , 1997, Cancer research.

[15]  C. Larsson,et al.  Allelic loss of the retinoblastoma tumor suppressor gene: a marker for aggressive parathyroid tumors? , 1996, The Journal of clinical endocrinology and metabolism.

[16]  V. Krutovskikh,et al.  Cx32 gene mutation in a chemically induced rat liver tumour. , 1996, Carcinogenesis.

[17]  M. Sheppard,et al.  Loss of heterozygosity studies at the retinoblastoma and breast cancer susceptibility (BRCA2) loci in pituitary, parathyroid, pancreatic and carcinoid tumours , 1996, Clinical endocrinology.

[18]  V. Krutovskikh,et al.  Human connexin 37 is polymorphic but not mutated in tumours. , 1996, Carcinogenesis.

[19]  N. Gilula,et al.  The Gap Junction Communication Channel , 1996, Cell.

[20]  V. Cryns,et al.  Genomic localization of novel candidate tumor suppressor gene loci in human parathyroid adenomas. , 1996, Cancer research.

[21]  A. Thor,et al.  Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma. , 1994, The New England journal of medicine.

[22]  L. Orci,et al.  Differential expression of gap junction connexins in endocrine and exocrine glands. , 1993, Endocrinology.

[23]  Sam W. Lee,et al.  Transcriptional downregulation of gap-junction proteins blocks junctional communication in human mammary tumor cell lines , 1992, The Journal of cell biology.

[24]  C. Marshall Tumor suppressor genes , 1991, Cell.

[25]  W. Loewenstein,et al.  Intercellular Communication and the Control of Tissue Growth: Lack of Communication between Cancer Cells , 1966, Nature.

[26]  R. Ruch Chapter 24: Role of Gap Junctions in Cellular Growth Control and Neoplasia: Evidence and Mechanisms , 1999 .

[27]  W. Zhu,et al.  Connexins in tumour suppression and cancer therapy. , 1999, Novartis Foundation symposium.

[28]  H. Yamasaki,et al.  Alterations of (CA)n DNA repeats and tumor suppressor genes in human gastric cancer. , 1994, Cancer research.